Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea

[1]  T. Bodmer,et al.  Carbapenemase-producing Klebsiella pneumoniae strains in Switzerland: Human and non-human settings may share high-risk clones. , 2022, Journal of global antimicrobial resistance.

[2]  L. Cerdeira,et al.  Whole-Genome Analysis of a High-Risk Clone of Klebsiella pneumoniae ST147 Carrying Both mcr-1 and blaNDM-1 Genes in Peru. , 2021, Microbial drug resistance.

[3]  Michael Y. Lin,et al.  Regional Spread of blaNDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Hamada,et al.  Characterization of bla NDM-5-harbouring Klebsiella pneumoniae sequence type 11 international high-risk clones isolated from clinical samples in Yangon General Hospital, a tertiary-care hospital in Myanmar. , 2021, Journal of medical microbiology.

[5]  A. Carattoli,et al.  Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  Á. Soriano,et al.  Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions. , 2020, The Journal of antimicrobial chemotherapy.

[7]  G. Peirano,et al.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147 , 2020, Antimicrobial Agents and Chemotherapy.

[8]  S. Jahan,et al.  Novel Carbapenem-Resistant Klebsiella pneumoniae ST147 Coharboring blaNDM-1, blaOXA-48 and Extended-Spectrum β-Lactamases from Pakistan , 2020, Infection and drug resistance.

[9]  Hong Zhang,et al.  Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai , 2019, BMC Infectious Diseases.

[10]  S. Hamada,et al.  Spreading Patterns of NDM-Producing Enterobacteriaceae in Clinical and Environmental Settings in Yangon, Myanmar , 2018, Antimicrobial Agents and Chemotherapy.

[11]  Eun-Jeong Yoon,et al.  Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. , 2018, Future microbiology.

[12]  L. Schouls,et al.  Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers , 2017, Journal of Clinical Microbiology.

[13]  Jia Jun Lee,et al.  Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches. , 2016, The Journal of antimicrobial chemotherapy.

[14]  S. Conlan,et al.  Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying blaNDM-1 on a Multidrug Resistance Plasmid , 2016, Genome Announcements.

[15]  X. Xia,et al.  Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China , 2016, Annals of Clinical Microbiology and Antimicrobials.

[16]  P. Nordmann,et al.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance , 2015, Antimicrobial Agents and Chemotherapy.

[17]  Mina Kim,et al.  Nosocomial Clustering of NDM-1-Producing Klebsiella pneumoniae Sequence Type 340 Strains in Four Patients at a South Korean Tertiary Care Hospital , 2012, Journal of Clinical Microbiology.

[18]  James R. Johnson,et al.  Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. , 2009, The Journal of antimicrobial chemotherapy.

[19]  I. Damjanova,et al.  Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'? , 2008, The Journal of antimicrobial chemotherapy.

[20]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[21]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .